SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla shares rallied as investors anticipated the company's invite-only Cybercab launch event in Austin. Despite the pre-event gains, many traders expressed skepticism regarding the event's secrecy and lack of a public livestream, leading to widespread debate over whether the stock will face a 'sell-the-news' pullback.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon shares dropped sharply following an earnings report that missed revenue expectations and featured a significant downward revision to full-year guidance. While some investors argue the stock is oversold, the community is debating whether the brand faces a structural decline due to increased competition and shifting consumer spending habits.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors await the upcoming quarterly earnings report, with the conversation dominated by speculation regarding potential short-squeeze dynamics and the impact of the company's enterprise AI orchestration strategy on future growth. While some traders express optimism about fundamental improvements and institutional accumulation, others remain cautious, debating the valuation and the sustainability of recent price gains.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood is trending as traders react to multiple analyst upgrades and strong interest in new product offerings like prediction markets and the Robinhood Chain. While bullish sentiment is fueled by expectations of a growth cycle and increased fee revenue, some traders express frustration over price volatility, suspecting artificial suppression by market makers.

Planet Labs PBC provides daily data and insights about earth. It offers a web-geo platform with satellite data available and foundational analytics to derive insights to make decisions. The company is founded by William S. Marshall and Robert H. Schingler in 2010 and is headquartered in San Francisco, CA.

Planet Labs PBC - Ordinary Shares - Class A

Planet Labs PBC

Planet Labs shares moved sharply higher after the company reported a double beat, with revenue and earnings surpassing analyst expectations despite a softer outlook for the next quarter. While some traders expressed concern over third-quarter guidance, the community consensus generally interprets the results as a sign of strong execution, with particular enthusiasm for the defense and intelligence segment growth and robust order backlog.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign is trending following positive fiscal second-quarter earnings that surpassed analyst expectations for both EPS and revenue, alongside a raised annual recurring revenue growth outlook driven by momentum in its Intelligent Agreement Management (IAM) platform. While many traders have responded positively to the beats and raised guidance, the conversation remains polarized, with some investors expressing skepticism about the company's long-term competitive moat against free e-signature alternatives and broader AI disruption concerns.

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscaler is trending as traders analyze a quarterly report featuring a double beat on top and bottom-line estimates alongside raised fiscal year guidance, though sentiment remains tempered by slowing growth in high-value customers. While many investors express long-term optimism regarding the stock's valuation relative to cybersecurity peers and its role in AI security, others highlight technical selling and a cautious outlook from management.

Samsara, Inc. develops internet connected sensor systems. It combines plug-and-play sensors, wireless connectivity, and cloud-hosted software integrated for deployment. The company was founded by John Bicket and Sanjit Biswas in 2015 and is headquartered in San Francisco, CA.

Samsara Inc - Ordinary Shares - Class A

Samsara Inc

Samsara shares are trending following a strong quarterly earnings report that beat revenue and profit expectations, supported by raised guidance and positive analyst sentiment regarding its AI-driven connected operations platform. Traders are focused on the company's momentum with large customers and its effective shift toward profitability, though some debate the sustainability of these gains given the software sector's overall volatility.

FLOKI is a community-driven, multi-chain utility token that powers a broad ecosystem including decentralized gaming, finance, and educational platforms. Originally evolving from a meme-based asset, the project now focuses on a utility-driven model centered around three pillars: community engagement, technical utility, and global charity work, balancing this ecosystem growth with social impact, such as building schools in developing nations like Ghana and Nigeria.  Key features include Valhalla, an NFT metaverse game where the token serves as the primary currency for capturing creatures and upgrading characters. The ecosystem also features the FlokiFi Locker for securing digital assets and the University of FLOKI for web3 education,with real-world integration facilitated through a prepaid debit card for everyday purchases at global stores. Staking FLOKI allows users to earn rewards in a sister token.  The project is led by a group of core advisors known by pseudonyms such as Sabre and B (The Viking) and is officially backed by DWF Labs, a major digital asset investment firm and market maker. While a small tax on decentralized trades helps fund development, value moves through the system as users utilize the token to pay for in-game items, access asset-locking services, or purchase merchandise.

Floki Token

Floki is currently trending as members of the community debate its long-term potential compared to other meme coins, frequently citing its established ecosystem, utility developments, and ongoing marketing efforts as reasons for their bullish outlook. While some traders express frustration with the recent price performance and market volatility, others emphasize a commitment to holding, viewing the current levels as a buying opportunity based on their belief in the token's infrastructure.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is experiencing significant price volatility following a proposed $500 million stock offering, which triggered community debate over dilution and capital management. Traders are closely monitoring this development alongside ongoing anticipation for the upcoming FDA PDUFA date for ivonescimab, with many bulls pointing to substantial recent insider buying as a sign of long-term conviction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September

Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will participate in fireside chats at the following investor conferences in September: Wells Fargo 21st Annual Healthcare Conference: Exelixis is scheduled to present at 11:00 a.m. ET / 8:00 a.m. PT on Tuesday, September 8 in...

Exelixis Announces Update on Patent Litigation Trial Appeal with MSN Laboratories

Exelixis, Inc. (Nasdaq: EXEL) today announced that in the lawsuit Exelixis, Inc. (Exelixis) vs. MSN Laboratories Private Limited et al. (MSN), Civil Action No. 22-00228 (Consolidated), the U.S. Court of Appeals for the Federal Circuit (Appeal No. 25-1236) has affirmed a key portion of the 2024...

Why Exelixis (EXEL) is a Top Growth Stock for the Long-Term

Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm Kuehn Law Encourages Investors of EXELIXIS, Inc. to Contact Law Firm PR Newswire NEW YORK, Aug. 19, 2026 NEW YORK, Aug. 19, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain...

Here's Why Exelixis (EXEL) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Exelixis (EXEL) Securities Investigation Notice - Levi & Korsinsky

Exelixis (EXEL) Securities Investigation Notice - Levi & Korsinsky Exelixis (EXEL) Securities Investigation Notice - Levi & Korsinsky PR Newswire NEW YORK, Aug. 17, 2026 Exelixis posted second-quarter revenue of approximately $628.7 million -- short of Wall Street consensus -- and shares sold off...

EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (SBS), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Exelixis, Inc. (Exelixis or the Company) (NASDAQ: EXEL) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on...

EXEL Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Exelixis (EXEL)

Exelixis (NASDAQ: EXEL) shares dropped in after-hours trading after the Company reported Q2 revenue of approximately $628.7 million, missing consensus estimates, and lowered and narrowed its full-year 2026 revenue outlook. If you suffered a loss on your Exelixis investment, you are encouraged to...

EXEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Exelixis

EXEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Exelixis EXEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Exelixis PR Newswire NEW YORK, Aug. 11, 2026 Exelixis lowered and narrowed its...

• Reported GAAP EPS of $0.85 up 25.00% YoY
• Reported revenue of $628.69M up 10.63% YoY
• Exelixis updated its fiscal year 2026 guidance, now projecting total revenues of $2.500 billion to $2.550 billion and net product revenues of $2.300 billion to $2.350 billion for the company.

Exelixis faces clinical trial uncertainty with non-statistically significant results in the STELLAR-303 subgroup, increased research and development spending, and revenue guidance that excludes potential contributions from the zanzalintinib commercial launch.

Exelixis demonstrated revenue growth driven by cabozantinib sales, maintained disciplined capital allocation through significant stock repurchases, and continues to expand the clinical development pipeline for its next-generation molecule, zanzalintinib.

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Exelixis Inc

Top 5 Biotech Stocks That Got Most Retail Buzz Last Week

Equity

Neutral Sentiment

The Federal Reserve hasn't raised rates at all in 2026, but hawkish comments from Fed Chair Kevin Warsh at the Jackson Hole symposium have pushed September rate hike odds as high as 66%, a sharp jump from under 40% just a week earlier. How many rate hikes do you expect from the Fed in 2026? Vote and explain your reasoning in the comments.

How many rate hikes do you expect from the Fed in 2026?

Current Price	$59.13
Prev Close	$58.53
Open	$58.75
Dividend Yield	0.00%
50-Day Moving Average	$54.93
Beta	0.50
Avg. Volume	2.59M
PE Ratio	18.57

52-Week High	$59.72
52-Week Low	$33.76
Market Capitalization	$14.5B
EPS (Annual)	$2.78
Price to Book	7.98
Revenue Per Employee	$2.15M

Feed

News

Sentiment

Earnings

Fundamentals

Info

EXEL Fundamentals